Sgeng

The article you linked was published 12 years ago, so clearly there has been quite some time between the event and the current person you are today. That leads me to ask: you’ve presented your viewpoints in a fairly calm, coherent way in this post that might invite debate. Do you remember how you presented such viewpoints in the class, as a much younger person?

I’m not trying to insinuate that you deserved to be treated the way you were, it just strikes me as REALLY strange that your classmates and professor would react in such a way given how you present the event in the post.

“For the converted and curious” converted from what? To what? Curious about what?

Hey, sorry if I wasn’t clear, but I was specifically asking about the way that your presented your argument during class, not how you were socially in general. It’s perfectly possible to be friendly and affable generally but during a serious discussion on a topic you are passionate about present your views in a different way. Certainly I know I’ve experienced times when I’ve talked about something I feel strongly about and I use very strong expressions/verbiage because I’m fired up at the time.

Appreciate the reply.

So what sets you apart as a service and what value does being centered around cannabis bring to a streaming platform?

How much does the platform revolve around cannabis? Could I find something like family guy on your service (if not now then eventually)?

To say that “making it a pure-play pharma project puts the focus on high drug prices” is just flat out wrong. How can you possibly ignore the pharmacies and PBMs (pharmacy benefit managers) that contribute hugely to the current drug price ecosystem? PBMs negotiate with drug makers to secure large rebates in exchange for being “in formulary” for pharmacies and insurance plans. The 3 biggest PBMs have control over 80% of the market and they use that immense power to negotiate large %-based rebates on each drug AND receive a percent off of each prescription of the drug, giving them massive incentive to push for HIGHER list prices of drugs.